These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 904588)

  • 1. [Current views on factors of fibrinogen synthesis and catabolism and on their possible role in the etiology of thromboembolic disease and atherosclerosis].
    Lepsanović L
    Med Pregl; 1977; 30(5-6):295-300. PubMed ID: 904588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of plasma-protein paracoagulation test in the diagnosis of thromboembolic the disease].
    Braun P; Meskó E; Gedeon A
    Z Gesamte Inn Med; 1976 Sep; 31(18):758-9. PubMed ID: 1007337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation.
    Watson T; Shantsila E; Lip GY
    Int J Cardiol; 2007 Aug; 120(1):123-4; author reply 125-6. PubMed ID: 17055595
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Agreement between possible and actual results in preventive treatment of postoperative thromboembolic complications].
    Păunescu V; Popa F; Cîrîc G; Simici P
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1987; 36(5):373-80. PubMed ID: 2964064
    [No Abstract]   [Full Text] [Related]  

  • 6. Levels of plasma fibrinogen and D-dimer in subjects with subclinical hyperthyroidism.
    Coban E; Aydemir M
    Med Sci Monit; 2008 Jan; 14(1):CR42-46. PubMed ID: 18160944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is the biological diagnosis of thromboembolic venous disease possible?].
    de Moerloose P; Bounameaux H
    Rev Prat; 1991 Apr; 41(11):999-1001. PubMed ID: 2063114
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitral regurgitation reduces systemic coagulation activity in rheumatic heart disease: using fibrin D-dimer as a biomarker of thrombogenesis.
    Tay KH; Khoo CW; Lip GY
    J Heart Valve Dis; 2009 May; 18(3):276-7. PubMed ID: 19557982
    [No Abstract]   [Full Text] [Related]  

  • 10. [Soluble fibrin monomer complexes in thromboembolism].
    Gryglik J
    Przegl Lek; 1982 Sep; 39(8):551-3. PubMed ID: 6753042
    [No Abstract]   [Full Text] [Related]  

  • 11. Proper observation of patient-related factors is an important determinant in the use of the D-dimer test for exclusion of venous thromboembolism in the ED.
    Houdijk WP
    Am J Emerg Med; 2007 Feb; 25(2):255-6. PubMed ID: 17276847
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum fatty acids and the importance of their determination in medicine].
    Lepsanović L
    Med Pregl; 1981; 34(1-2):71-81. PubMed ID: 7290004
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood markers of cardiovascular disease.
    Gershlick AH
    Eur Heart J; 1999 Oct; 20(20):1443-4. PubMed ID: 10493839
    [No Abstract]   [Full Text] [Related]  

  • 14. The coagulation and fibrinolysis systems and atherosclerosis.
    Tanaka K; Sueishi K
    Lab Invest; 1993 Jul; 69(1):5-18. PubMed ID: 8331898
    [No Abstract]   [Full Text] [Related]  

  • 15. Identifying patients at risk of recurrent venous thromboembolism.
    Brotman DJ
    JAMA; 2003 Dec; 290(24):3192; author reply 3192. PubMed ID: 14693866
    [No Abstract]   [Full Text] [Related]  

  • 16. A very elevated D-dimer level may potentially be useful.
    Heath R; Horton S; Martlew V; Thachil J
    Eur J Intern Med; 2013 Mar; 24(2):e19-20. PubMed ID: 23044170
    [No Abstract]   [Full Text] [Related]  

  • 17. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats.
    Nieuwenhuizen W; Emeis JJ; Vermond A
    Thromb Haemost; 1982 Aug; 48(1):59-61. PubMed ID: 7135343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of Kupffer cells and hepatocytes in fibrinogen catabolism].
    Davydov VS; Subkhankulova FB; Litvinov RI; Zubairov DM
    Vopr Med Khim; 1982; 28(4):83-6. PubMed ID: 7113060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performances of the VIDAS D-dimer new assay for the exclusion of venous thromboembolism.
    de Moerloose P; Bounameaux H; Perrier A; Reber G
    Thromb Haemost; 2001 Jan; 85(1):185-6. PubMed ID: 11204577
    [No Abstract]   [Full Text] [Related]  

  • 20. [Apo B, fibrinogen-fibrin and fibronectin in the intima of the normal human aorta and large arteries and in atherosclerosis].
    Shekhonin BV; Tararak EM; Samokhin GP; Vinogradov DV; Kotelianskiĭ VE
    Arkh Patol; 1990; 52(4):16-21. PubMed ID: 2201275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.